INTERACTION OF KETOCONAZOLE WITH RIFAMPIN AND ISONIAZID

被引：91

作者：

ENGELHARD, D ^{[1
]}

STUTMAN, HR ^{[1
]}

MARKS, MI ^{[1
]}

机构：

[1] UNIV OKLAHOMA,HLTH SCI CTR,DEPT PEDIAT,OKLAHOMA CITY,OK 73190

来源：

NEW ENGLAND JOURNAL OF MEDICINE | 1984年 / 311卷 / 26期

关键词：

D O I：

10.1056/NEJM198412273112606

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1681 / 1682

页数：2

共 15 条

[1] CLINICAL PHARMACOKINETICS OF RIFAMPICIN [J].

ACOCELLA, G .

CLINICAL PHARMACOKINETICS, 1978, 3 (02) :108-127

[2] SERUM CONCENTRATION AND HALF-LIFE OF RIFAMPICIN AFTER SIMULTANEOUS ORAL-ADMINISTRATION OF AMINOSALICYLIC ACID OR ISONIAZID [J].

BOMAN, G .

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1974, 7 (03) :217-225

[3] DISPOSITION OF KETOCONAZOLE, AN ORAL ANTIFUNGAL, IN HUMANS [J].

BRASS, C ;

GALGIANI, JN ;

BLASCHKE, TF ;

DEFELICE, R ;

OREILLY, RA ;

STEVENS, DA .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1982, 21 (01) :151-158

[4] PHARMACOKINETICS OF KETOCONAZOLE IN NORMAL SUBJECTS [J].

DANESHMEND, TK ;

WARNOCK, DW ;

TURNER, A ;

ROBERTS, CJC .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1981, 8 (04) :299-304

[5]

GRAYBILL JR, 1983, REV INFECT DIS, V5, pS620

[6] KETOCONAZOLE - A REVIEW OF ITS THERAPEUTIC EFFICACY IN SUPERFICIAL AND SYSTEMIC FUNGAL-INFECTIONS [J].

HEEL, RC ;

BROGDEN, RN ;

CARMINE, A ;

MORLEY, PA ;

SPEIGHT, TM ;

AVERY, GS .

DRUGS, 1982, 23 (1-2) :1-36

[7]

JORGENSEN JH, 1981, ANTIMICROB AGENTS CH, V20, P59, DOI 10.1128/AAC.20.1.59

[8] RIFAMPICIN REDUCES EFFECTIVENESS AND BIOAVAILABILITY OF PREDNISOLONE [J].

MCALLISTER, WAC ;

THOMPSON, PJ ;

ALHABET, SM ;

ROGERS, HJ .

BRITISH MEDICAL JOURNAL, 1983, 286 (6369) :923-925

[9]

MEDOFF G, 1983, REV INFECT DIS, V5, pS614

[10]

MEUNIERCARPENTI.F, 1983, 23RD INT C ANT AG CH

← 1 2 →